Literature DB >> 7946350

Myosin II is involved in transmitter release at synapses formed between rat sympathetic neurons in culture.

S Mochida1, H Kobayashi, Y Matsuda, Y Yuda, K Muramoto, Y Nonomura.   

Abstract

The presynaptic function of myosin II was studied at cholinergic synapses formed between rat superior cervical ganglion neurons in culture. Immunofluorescent staining showed that myosin II was colocalized with synaptophysin at the presynaptic nerve terminals. Antimyosin II antibody introduced into presynaptic neurons inhibited synaptic transmission. Transmission was also inhibited in a dose-dependent manner by two inhibitors of myosin light chain kinase: a peptide, SM-1, and an organic inhibitor, wortmannin. The inhibition produced by these agents was dependent on presynaptic activity. Extracellularly applied wortmannin also blocked synaptic transmission, but its effects were slower in onset. Wortmannin also decreased postsynaptic potentials and post-tetanic potentiation in intact superior cervical ganglia. These results suggest a model in which myosin light chain kinase phosphorylates myosin, and the resultant change in actin-myosin interactions is involved in neurotransmitter release.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946350     DOI: 10.1016/0896-6273(94)90051-5

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  53 in total

1.  Presynaptic mitochondria and the temporal pattern of neurotransmitter release.

Authors:  L Brodin; L Bakeeva; O Shupliakov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

2.  Subtype-selective reconstitution of synaptic transmission in sympathetic ganglion neurons by expression of exogenous calcium channels.

Authors:  Sumiko Mochida; Ruth E Westenbroek; Charles T Yokoyama; Kanako Itoh; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

3.  The human submandibular gland: immunohistochemical analysis of SNAREs and cytoskeletal proteins.

Authors:  Mechthild Stoeckelhuber; Elias Q Scherer; Klaus-Peter Janssen; Julia Slotta-Huspenina; Denys J Loeffelbein; Nils H Rohleder; Markus Nieberler; Rafael Hasler; Marco R Kesting
Journal:  J Histochem Cytochem       Date:  2011-11-30       Impact factor: 2.479

4.  Mammalian homolog of Drosophila tumor suppressor lethal (2) giant larvae interacts with basolateral exocytic machinery in Madin-Darby canine kidney cells.

Authors:  Anne Müsch; David Cohen; Charles Yeaman; W James Nelson; Enrique Rodriguez-Boulan; Patrick J Brennwald
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

5.  Inhibitors of myosin light chain kinase block synaptic vesicle pool mobilization during action potential firing.

Authors:  T A Ryan
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

6.  Role of the Doc2 alpha-Munc13-1 interaction in the neurotransmitter release process.

Authors:  S Mochida; S Orita; G Sakaguchi; T Sasaki; Y Takai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

7.  Traffic of dynamin within individual Drosophila synaptic boutons relative to compartment-specific markers.

Authors:  P S Estes; J Roos; A van der Bliek; R B Kelly; K S Krishnan; M Ramaswami
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

8.  Regulation of NMDA receptor activity by F-actin and myosin light chain kinase.

Authors:  S Lei; E Czerwinska; W Czerwinski; M P Walsh; J F MacDonald
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

9.  The role of myosin in vesicle transport during bovine chromaffin cell secretion.

Authors:  Patricia Neco; Anabel Gil; María Del Mar Francés; Salvador Viniegra; Luis M Gutiérrez
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

10.  Myosin II motor proteins with different functions determine the fate of lamellipodia extension during cell spreading.

Authors:  Venkaiah Betapudi
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.